|4Feb 14, 7:32 PM ET

Amin Naseem 4

4 · Bellerophon Therapeutics, Inc. · Filed Feb 14, 2023

Insider Transaction Report

Form 4
Period: 2023-02-10
Amin Naseem
Director
Transactions
  • Award

    Common Stock

    2023-02-10+84,000244,287 total
Footnotes (1)
  • [F1]RSAs fully vested on grant date.

Documents

1 file
  • 4
    form4-02152023_120207.xmlPrimary